Elizabeth Yeu Lin, Chief Medical Officer, on September 04, 2026, sold 13,953 shares in Tarsus Pharmaceuticals (TARS) for $1,220,885. Following the Form 4 filing with the SEC, Lin has control over a total of 16,177 common shares of the company, with 2,547 shares held directly and 13,630 controlled indirectly.
SEC Filing:
Hugh H McLean, Director, on September 08, 2026, sold 25,000 shares in Old Second Bancorp (OSBC) for $640,768. Following the Form 4 filing with the SEC, McLean has control over a total of 135,351 common shares of the company, with 135,351 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/357173/000118476426000008/xslF345X05/form4-09082026_090934.xml
Mark A Stevens, Director, on September 03, 2026, sold 1,022,239 shares in Nvidia (NVDA) for $235,636,867. Following the Form 4 filing with the SEC, Stevens has control over a total of 28,898,893 common shares of the company, with 11,544,612 shares held directly and 17,354,281 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1045810/000119903926000014/xslF345X05/wk-form4_1788901755.xml
Anton J Levy, Director, on September 03, 2026, sold 340,000 shares in Warner Bros. Discovery (WBD) for $9,652,600. Following the Form 4 filing with the SEC, Levy has control over a total of 618,067 Series A common shares of the company, with 618,067 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1437107/000139668126000004/xslF345X05/wk-form4_1788901160.xml